EP300 and nasopharyngeal carcinoma: Our findings provide a basis for the concept that high expression of p300 may play an important role in the acquisition of an aggressive phenotype in NPC, suggesting that the expression of p300, as examined by IHC, will be a promising independent biomarker for shortened survival time of NPC patients.